Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study (Q53900090)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q39375925)
(P304) 2132-2139
(P407) (Q1860)
(P433) 7
(P478) 36
(P577) Friday, December 1, 2000
(P921) (Q844935)
(P1433) (Q2984355)
(P1476) "Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study" (language: en)
(P2093) Laham RJ
Chronos NA
Pike M
Leimbach ME
Udelson JE
Pearlman JD
Pettigrew RI
Whitehouse MJ
Yoshizawa C
(P2860) (Q46018766)
(Q68199451)
(Q55067407)
(Q41740363)
(Q40377374)
(Q41185967)
(Q40403288)
(Q68066299)
(Q34242525)
(Q71601184)
(Q59619014)
(Q45879668)
(Q27732601)
(Q24561731)
(Q42816414)
(Q40935731)
(Q41505290)
(Q67542808)
(Q71599598)
(Q47265328)
(Q33490052)
(Q34228938)
(Q53556772)
(Q53572788)
(Q71563623)
(Q72260904)
(Q77615168)
(Q67847584)
(Q78167219)
(Q41139521)
(Q35597553)
(Q59067674)
(Q73083024)
(Q52891274)
(Q74780606)
(Q52220720)
(Q38477300)
(Q74773975)
(Q77809484)
(Q73142282)
(Q37376876)
other details
description scientific article

External Links